Other languages Numinus Wellness Inc.

Equities

NUMI

CA67054W1032

Market Closed - Toronto S.E. Other stock markets 01:17:55 01/05/2024 am IST			5-day change	1st Jan Change
0.075 ^CAD	-.--%		-11.76%	-31.82%

17/04	Numinus Wellness Brief: Says Cedar Clinical Research Selected as clinical research site for Cybin's Phase 3 Study of CYB003	MT
17/04	Cybin Selects Numinus Wellness Inc.'s Cedar Clinical Research as clinical research site for Its Phase 3 Study of CYB003	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cybin Selects Numinus Wellness Inc.'s Cedar Clinical Research as clinical research site for Its Phase 3 Study of CYB003	17/04
Numinus Wellness Drops 25% as it Explores Options for its Canadian Operations; FQ2 Profit Falls	15/04
Numinus Wellness Exploring Options For Canadian Operations; Comes After It Posted QoQ Decrease in Q2 Revenue, Gross Profit	15/04
Numinus Wellness Posts QoQ Decrease in Q2 Revenue, Gross Profit	15/04
Numinus Wellness Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	13/04
Numinus Wellness Inc. Submits Clinical Trial Application	20/03
Numinus Wellness Inc. Announces Board Changes	12/03
Numinus Wellness Closes $6 Million Bought Deal Public Offering	16/02
Numinus Wellness Inc.: Numinus Wellness Inc. gratuliert Lykos Therapeutics zur FDA-Zulassung eines Antrags für ein neues Arzneimittel für die MDMA-gestützte Therapie bei der posttraumatischen Belastungsstörung	15/02
Numinus Wellness Inc.: Numinus Wellness Inc. kündigt Bought Deal-Emission in Höhe von 6 Mio. $ mit Lead-Orders von MAPS und Integrated V.C. an	05/02
Numinus Wellness Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	16/01
Beckley Psytech Selects Numinus Wellness' Cedar Clinical Research as Clinical Research Site for Phase 2b Study	15/12
Cedar Clinical Research Selected as Clinical Research Site for Beckley Psytech's Phase 2B Study	15/12
Numinus Wellness Q4 2023 Revenues Grew Near 50% YoY	30/11
Numinus Wellness Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	29/11
Numinus Wellness Inc. Introduces Its Innovative and Comprehensive Psychedelic Program for Individuals Surging from Mental Distress Associated with Chronic and Serious Illness Through Cedar Clinical Research	03/23/03
Numinus Wellness Takes Steps to Cut Costs, Pursue Positive Cash-Flow Generation; Down 4.4%	19/23/19
Numinus Wellness Posts Q3 Net Loss, Revenue Up QoQ	18/23/18
Numinus Wellness Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	18/23/18
Numinus Announces Agreement with Healingmaps to Drive Strategic Clinic Growth	22/23/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Numinus Wellness Inc.

Equities

NUMI

CA67054W1032

Other languages

Filters